Glassman Wealth Services Heron Therapeutics, Inc. Transaction History

Glassman Wealth Services

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$2.3 - $6.29 $80 - $220	35 New	35 $0
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $1,352 - $2,041	-162 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$10.23 - $24.56 $10,230 - $24,560	-1,000 Reduced 86.06%	162 $2,000
Q4 2019 Feb 07, 2020	BUY	$17.42 - $26.61 $17,420 - $26,610	1,000 Added 617.28%	1,162 $27,000
Q3 2019 Nov 01, 2019	SELL	$16.36 - $21.39 $327 - $427	-20 Reduced 10.99%	162 $3,000
Q2 2019 Aug 08, 2019	BUY	$16.93 - $26.22 $338 - $524	20 Added 12.35%	182 $3,000
Q4 2018 Feb 06, 2019	BUY	$22.03 - $32.01 $3,568 - $5,185	162 New	162 $4,000

175

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $202M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.